5398
慕康生醫
+0.05 (+0.35%)14.2576成交張數142.50本益比1.36股價淨值比0.00%殖利率2026-09-11資料日期
毛利率、營業利益率、淨利率
單季;近十年
單季營收
億元
| 季度 | 營收(億) | 營收年增 | 毛利(億) | 毛利率 | 營業利益(億) | 營業利益率 | 淨利率 |
|---|---|---|---|---|---|---|---|
| 2026Q2 | 0.4 | -48.8% | 0.1 | 35.8% | 0.0 | 3.0% | 18.2% |
| 2026Q1 | 0.3 | 12.8% | 0.0 | 0.5% | -0.1 | -43.3% | -37.9% |
| 2025Q4 | 0.6 | -15.8% | 0.2 | 37.9% | 0.0 | 3.6% | 5.2% |
| 2025Q3 | 0.7 | 5.5% | 0.3 | 35.7% | 0.1 | 10.2% | 8.1% |
| 2025Q2 | 0.8 | 16.9% | 0.4 | 52.6% | 0.2 | 21.8% | 24.1% |
| 2025Q1 | 0.3 | -33.5% | -0.0 | -6.7% | -0.1 | -54.5% | -38.0% |
| 2024Q4 | 0.7 | 83.8% | 0.2 | 30.6% | -0.0 | -0.9% | -2.3% |
| 2024Q3 | 0.7 | 36.6% | 0.2 | 35.5% | 0.0 | 7.2% | 3.9% |
| 2024Q2 | 0.7 | 15.6% | 0.3 | 40.7% | 0.1 | 8.0% | 11.9% |
| 2024Q1 | 0.4 | -23.0% | 0.1 | 34.6% | -0.0 | -8.9% | 3.9% |
| 2023Q4 | 0.4 | -52.0% | 0.0 | 6.7% | -0.1 | -39.3% | -35.7% |
| 2023Q3 | 0.5 | -16.7% | 0.1 | 20.6% | -0.1 | -16.4% | -10.0% |
| 2023Q2 | 0.6 | -13.6% | 0.1 | 25.8% | -0.0 | -8.3% | 0.3% |
| 2023Q1 | 0.5 | -11.8% | 0.1 | 12.3% | -0.1 | -27.8% | -28.1% |
| 2022Q4 | 0.7 | 15.2% | 0.1 | 18.7% | -0.0 | -6.7% | -9.2% |
| 2022Q3 | 0.6 | -10.3% | 0.1 | 23.0% | -0.0 | -8.0% | -0.4% |
| 2022Q2 | 0.7 | -49.6% | 0.2 | 30.7% | 0.0 | 1.5% | 7.7% |
| 2022Q1 | 0.6 | -36.3% | 0.2 | 31.3% | -0.0 | -6.5% | -8.2% |
| 2021Q4 | 0.6 | -39.4% | 0.2 | 28.1% | -0.1 | -9.2% | -4.4% |
| 2021Q3 | 0.7 | -24.2% | 0.2 | 35.9% | 0.0 | 6.2% | 0.1% |
| 2021Q2 | 1.3 | 53.9% | 0.4 | 32.8% | 0.2 | 14.5% | 8.7% |
| 2021Q1 | 0.9 | 2.0% | 0.3 | 36.4% | 0.1 | 7.5% | 8.5% |
| 2020Q4 | 1.1 | -4.6% | 0.4 | 33.4% | 0.1 | 6.1% | 10.6% |
| 2020Q3 | 0.9 | -13.7% | 0.3 | 33.9% | 0.0 | 3.0% | -0.8% |
| 2020Q2 | 0.8 | -25.7% | 0.3 | 33.9% | 0.0 | 0.0% | 2.9% |
| 2020Q1 | 0.9 | -15.9% | 0.3 | 36.3% | 0.0 | 3.4% | 4.0% |
| 2019Q4 | 1.1 | -26.6% | 0.4 | 38.3% | 0.1 | 8.8% | 19.7% |
| 2019Q3 | 1.0 | -22.6% | 0.3 | 30.7% | -0.1 | -5.1% | 0.1% |
| 2019Q2 | 1.1 | -6.5% | 0.3 | 28.6% | -0.0 | -1.0% | 4.5% |
| 2019Q1 | 1.0 | -16.1% | 0.3 | 29.1% | -0.0 | -2.3% | -1.9% |
| 2018Q4 | 1.5 | 22.4% | 0.5 | 29.5% | 0.0 | 1.2% | 12.3% |
| 2018Q3 | 1.3 | -1.2% | 0.3 | 25.4% | -0.1 | -8.9% | -30.7% |
| 2018Q2 | 1.2 | -7.0% | 0.2 | 17.1% | -0.3 | -21.5% | -29.5% |
| 2018Q1 | 1.2 | -19.5% | 0.4 | 30.0% | -0.0 | -2.8% | -3.6% |
| 2017Q4 | 1.2 | -21.8% | 0.4 | 30.7% | -0.1 | -11.7% | -16.5% |
| 2017Q3 | 1.3 | 98.1% | 0.3 | 25.3% | -0.1 | -9.2% | 4.0% |
| 2017Q2 | 1.3 | 148.1% | 0.5 | 35.2% | -0.0 | -2.3% | 5.8% |
| 2017Q1 | 1.6 | 188.3% | 0.6 | 37.1% | 0.2 | 15.9% | 16.6% |
| 2016Q4 | 1.6 | – | 0.5 | 33.5% | 0.1 | 9.2% | 8.8% |
| 2016Q3 | 0.7 | – | 0.2 | 30.6% | -0.0 | -2.8% | -0.0% |